Specificity of protection of man immunized against sporozoite-induced falciparum malaria.
about
Acquired immunity to malariaMolecular dissection of the human antibody response to the structural repeat epitope of Plasmodium falciparum sporozoite from a protected donorPlasmodium vivax Controlled Human Malaria Infection - Progress and ProspectsTranscriptional analysis of the pre-erythrocytic stages of the rodent malaria parasite, Plasmodium yoeliiPhase I trial of an alhydrogel adjuvanted hepatitis B core virus-like particle containing epitopes of Plasmodium falciparum circumsporozoite protein.A role for immune responses against non-CS components in the cross-species protection induced by immunization with irradiated malaria sporozoites.Why functional pre-erythrocytic and bloodstage malaria vaccines fail: a meta-analysis of fully protective immunizations and novel immunological model.Artesunate versus chloroquine infection-treatment-vaccination defines stage-specific immune responses associated with prolonged sterile protection against both pre-erythrocytic and erythrocytic Plasmodium yoelii infection.Population structure and recent evolution of Plasmodium falciparumgammadelta T cells are a component of early immunity against preerythrocytic malaria parasites.Circumsporozoite protein-specific K(d)-restricted CD8+ T cells mediate protective antimalaria immunity in sporozoite-immunized MHC-I-K(d) transgenic mice.HLA-A2 supertype-restricted cell-mediated immunity by peripheral blood mononuclear cells derived from Malian children with severe or uncomplicated Plasmodium falciparum malaria and healthy controls.Short-term antigen presentation and single clonal burst limit the magnitude of the CD8(+) T cell responses to malaria liver stages.Cross-protection between attenuated Plasmodium berghei and P. yoelii sporozoitesPoly(I:C) is an effective adjuvant for antibody and multi-functional CD4+ T cell responses to Plasmodium falciparum circumsporozoite protein (CSP) and αDEC-CSP in non human primates.Antibody and B cell responses to Plasmodium sporozoites.Immune responses and protection of Aotus monkeys immunized with irradiated Plasmodium vivax sporozoitesPre-erythrocytic-stage immune effector mechanisms in Plasmodium spp. infections.A next-generation genetically attenuated Plasmodium falciparum parasite created by triple gene deletion.Protective Efficacy of Plasmodium vivax Radiation-Attenuated Sporozoites in Colombian Volunteers: A Randomized Controlled Trial.Induction of multi-antigen multi-stage immune responses against Plasmodium falciparum in rhesus monkeys, in the absence of antigen interference, with heterologous DNA prime/poxvirus boost immunization.Circumsporozoite proteins of human malaria parasites Plasmodium falciparum and Plasmodium vivaxIrradiated sporozoite vaccine induces HLA-B8-restricted cytotoxic T lymphocyte responses against two overlapping epitopes of the Plasmodium falciparum sporozoite surface protein 2.Cross-species immunity in malaria vaccine development: two, three, or even four for the price of one?T lymphocytes from mice immunized with irradiated sporozoites eliminate malaria from hepatocytesPlasmodium falciparum antigenic diversity: evidence of clonal population structure.Mosquito bite immunization with radiation-attenuated Plasmodium falciparum sporozoites: safety, tolerability, protective efficacy and humoral immunogenicityPlasmodium falciparum-specific cellular immune responses after immunization with the RTS,S/AS02D candidate malaria vaccine in infants living in an area of high endemicity in Mozambique.Progress with Plasmodium falciparum sporozoite (PfSPZ)-based malaria vaccines.Model for in vivo assessment of humoral protection against malaria sporozoite challenge by passive transfer of monoclonal antibodies and immune serum.Plasmodium vivax Cell-Traversal Protein for Ookinetes and Sporozoites: Naturally Acquired Humoral Immune Response and B-Cell Epitope Mapping in Brazilian Amazon Inhabitants.The Threshold of Protection from Liver-Stage Malaria Relies on a Fine Balance between the Number of Infected Hepatocytes and Effector CD8+ T Cells Present in the LiverCD8(+) T Cell Responses to Plasmodium and Intracellular Parasites.Immunity to falciparum and vivax malaria induced by irradiated sporozoites: a review of the University of Maryland studies, 1971-75.Live attenuated pre-erythrocytic malaria vaccines.Pre-erythrocytic stage malaria parasites: non-circumsporozoite protein antigens.Human CD8+ T cells mediate protective immunity induced by a human malaria vaccine in human immune system mice.HLA-A*01-restricted cytotoxic T-lymphocyte epitope from the Plasmodium falciparum circumsporozoite protein.CD8+ T-cell mediated anti-malaria protection induced by malaria vaccines; assessment of hepatic CD8+ T cells by SCBC assay.A potent adjuvant effect of a CD1d-binding NKT cell ligand in human immune system mice.
P2860
Q24651173-FA6C7A88-FC3E-4B93-A528-4A07F939F837Q24798369-62CBF0D3-55C5-4C49-8A92-BB7F67A5D594Q28066456-EBE05B6A-1344-4DAE-AED1-62DD6AFE73A8Q28473729-0AF2AEC4-460A-4ACC-8A16-9671F0A445E5Q33318466-2910661A-4244-446C-8FA6-61F6B9A0127CQ33515022-06DAED48-A414-4C92-81C3-36B432C2A46DQ33587443-093F44B8-D9DE-42F2-9099-843D89B77CF9Q33927133-A0D51A96-AF17-4797-BD19-6CEC8F6FA562Q33946978-CB2FA164-81B2-450A-B471-FCB488293C2DQ34003993-A4B3FC95-7123-4C74-A3E4-9A8EE99E0B01Q34012311-6654BFD1-77F3-44E9-BA4D-C87F8A1D5132Q34034148-82204378-A314-4DD8-9E7F-42192309D000Q34154441-6511D45E-602A-4D1E-9CC6-E281E69209C1Q34204920-2416C2AE-3696-41E9-937A-328FC6E92136Q34416103-E53C4A8C-8763-463C-AA93-192A45D3BB59Q34530938-852B818F-E7BA-4278-A722-B0A3E2146EC2Q34546225-0A9BB8D9-0B62-41C7-BFE0-10CFAE9DB68BQ35211719-A6DAF08D-9ED5-4568-AFA7-A8171E3E5FCFQ35618598-F30FFB53-6061-41E2-9E30-45172B0AFEE1Q36167716-1CD0E454-F1B3-4355-8258-031A1356E1C9Q36285998-3557F754-CA40-47C7-9AEF-D8F1095B8558Q36346627-7948543B-1907-4169-A540-DDF22C98473EQ36365487-3FAFD6E8-AF77-423F-A3A3-CA6839941573Q36483682-2541BA70-1A4E-4EDD-AEBF-CD83DA424C2AQ36668544-62C7CE7F-98E3-4C22-9FE7-823803E7BC03Q36716289-B5ACBA86-A920-4FB5-A82D-D3CB38CC6F76Q37118222-FE2E8CF5-5545-4726-932A-E23F8674FA0EQ37355917-C3A21C29-6E60-4189-907A-7803EE08DC0AQ37361903-2735DDD0-90BF-4120-826B-0D62BEF1B69EQ37546462-09BA8E5E-250B-4297-9228-08F685A0EF1AQ37627098-AE7D6E6C-1FE8-483A-8FEA-6447B42B1475Q37654676-2B9068E4-0F11-4FCF-B4F3-CEB997B5835BQ37698282-B374B495-04B0-460C-BA35-2652610B9528Q37800094-868A5B7C-2E8F-4E12-8250-15A19C5220F4Q38284696-8620E614-6760-4F8E-B079-A5B1A33D8C18Q38591761-C039462F-6C6C-4C7B-BEB4-9233456A6196Q39510998-784BF1A5-9CFC-466C-BB39-92A37BDCCFA8Q39519692-CF4DB7E5-0A4E-442E-B066-90E0D107B0A7Q40270575-161B794A-4546-4D54-BDCF-9A84925BFAA0Q40500189-3695E918-7006-4867-8021-283678BB4CB1
P2860
Specificity of protection of man immunized against sporozoite-induced falciparum malaria.
description
1973 nî lūn-bûn
@nan
1973年の論文
@ja
1973年学术文章
@wuu
1973年学术文章
@zh
1973年学术文章
@zh-cn
1973年学术文章
@zh-hans
1973年学术文章
@zh-my
1973年学术文章
@zh-sg
1973年學術文章
@yue
1973年學術文章
@zh-hant
name
Specificity of protection of man immunized against sporozoite-induced falciparum malaria.
@en
Specificity of protection of man immunized against sporozoite-induced falciparum malaria.
@nl
type
label
Specificity of protection of man immunized against sporozoite-induced falciparum malaria.
@en
Specificity of protection of man immunized against sporozoite-induced falciparum malaria.
@nl
prefLabel
Specificity of protection of man immunized against sporozoite-induced falciparum malaria.
@en
Specificity of protection of man immunized against sporozoite-induced falciparum malaria.
@nl
P2093
P921
P1476
Specificity of protection of man immunized against sporozoite-induced falciparum malaria.
@en
P2093
P304
P407
P577
1973-12-01T00:00:00Z